Thoroughbred Financial Services’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.27M | Sell |
17,635
-133
| -0.7% | -$15.6K | 0.11% | 175 |
|
|
2026
Q1 | $2.14M | Buy |
17,768
+1,467
| +9% | +$169K | 0.13% | 154 |
|
|
2025
Q4 | $1.72M | Buy |
16,301
+207
| +1% | +$19.4K | 0.1% | 190 |
|
|
2025
Q3 | $1.35M | Sell |
16,094
-514
| -3% | -$42.3K | 0.08% | 225 |
|
|
2025
Q2 | $1.31M | Sell |
16,608
-10,504
| -39% | -$835K | 0.09% | 217 |
|
|
2025
Q1 | $2.43M | Sell |
27,112
-3,056
| -10% | -$285K | 0.15% | 145 |
|
|
2024
Q4 | $3M | Sell |
30,168
-2,743
| -8% | -$283K | 0.18% | 110 |
|
|
2024
Q3 | $3.74M | Sell |
32,911
-9,228
| -22% | -$1.1M | 0.24% | 81 |
|
|
2024
Q2 | $5.22M | Buy |
42,139
+6,291
| +18% | +$810K | 0.35% | 59 |
|
|
2024
Q1 | $4.73M | Sell |
35,848
-564
| -2% | -$69.5K | 0.46% | 53 |
|
|
2023
Q4 | $3.97M | Buy |
36,412
+3,125
| +9% | +$324K | 0.32% | 66 |
|
|
2023
Q3 | $3.43M | Buy |
33,287
+6,606
| +25% | +$712K | 0.34% | 65 |
|
|
2023
Q2 | $3.08M | Buy |
26,681
+865
| +3% | +$98.2K | 0.4% | 58 |
|
|
2023
Q1 | $2.75M | Buy |
25,816
+212
| +0.8% | +$22.9K | 0.41% | 66 |
|
|
2022
Q4 | $2.84M | Buy |
25,604
+372
| +1% | +$38K | 0.46% | 54 |
|
|
2022
Q3 | $2.17M | Buy |
25,232
+124
| +0.5% | +$11.1K | 0.41% | 59 |
|
|
2022
Q2 | $2.29M | Buy |
25,108
+7,121
| +40% | +$631K | 0.42% | 57 |
|
|
2022
Q1 | $1.48M | Buy |
17,987
+9,251
| +106% | +$729K | 0.24% | 102 |
|
|
2021
Q4 | $669K | Buy |
8,736
+896
| +11% | +$71.4K | 0.14% | 156 |
|
|
2021
Q3 | $588K | Buy |
7,840
+741
| +10% | +$56.4K | 0.14% | 153 |
|
|
2021
Q2 | $552K | Sell |
7,099
-275
| -4% | -$20.5K | 0.14% | 154 |
|
|
2021
Q1 | $542K | Buy |
7,374
+804
| +12% | +$59.3K | 0.15% | 151 |
|
|
2020
Q4 | $512K | Buy |
6,570
+50
| +0.8% | +$3.82K | 0.16% | 142 |
|
|
2020
Q3 | $516K | Buy |
6,520
+359
| +6% | +$28.1K | 0.19% | 127 |
|
|
2020
Q2 | $455K | Sell |
6,161
-9,646
| -61% | -$726K | 0.19% | 129 |
|
|
2020
Q1 | $1.16M | Buy |
15,807
+990
| +7% | +$77.8K | 0.41% | 75 |
|
|
2019
Q4 | $1.29M | Sell |
14,817
-364
| -2% | -$29.9K | 0.43% | 68 |
|
|
2019
Q3 | $1.22M | Buy |
15,181
+95
| +0.6% | +$7.61K | 0.46% | 62 |
|
|
2019
Q2 | $1.21M | Buy |
15,086
+1,018
| +7% | +$77.9K | 0.46% | 62 |
|
|
2019
Q1 | $1.12M | Buy |
14,068
+298
| +2% | +$22.3K | 0.46% | 63 |
|
|
2018
Q4 | $1M | Buy |
+13,770
| New | +$972K | 0.49% | 57 |
|
Other funds holding MRK
Thoroughbred Financial Services's MRK Position: Q2 2026 in Review
Thoroughbred Financial Services reduced its Merck (MRK) stake by 0.75% in Q2 2026, selling an estimated $15.6K and leaving 17,635 shares worth $2.27M. The position accounts for 0.11% of the portfolio, ranked #175.
Thoroughbred Financial Services first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.22M in Q2 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Thoroughbred Financial Services held 17,635 shares of Merck worth $2.27M as of Q2 2026.
- Thoroughbred Financial Services sold 133 Merck shares in Q2 2026, an estimated $15.6K.
- Merck made up 0.11% of Thoroughbred Financial Services's portfolio in Q2 2026, its #175 holding.
- Thoroughbred Financial Services first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Thoroughbred Financial Services's Merck position peaked at $5.22M in Q2 2024.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.